117 related articles for article (PubMed ID: 37552213)
1. The glycosylation defect in solute carrier SLC35A2/SLC35A3 double knockout cells is rescued by SLC35A2-SLC35A3 and SLC35A3-SLC35A2 hybrids.
Wiertelak W; Pavlovskyi A; Maszczak-Seneczko D; Szulc B; Olczak M
FEBS Lett; 2023 Sep; 597(18):2345-2357. PubMed ID: 37552213
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of GlcNAc-rich
Szulc B; Sosicka P; Maszczak-Seneczko D; Skurska E; Shauchuk A; Olczak T; Freeze HH; Olczak M
J Biol Chem; 2020 Nov; 295(48):16445-16463. PubMed ID: 32938718
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel potential interaction partners of UDP-galactose (SLC35A2), UDP-N-acetylglucosamine (SLC35A3) and an orphan (SLC35A4) nucleotide sugar transporters.
Wiktor M; Wiertelak W; Maszczak-Seneczko D; Balwierz PJ; Szulc B; Olczak M
J Proteomics; 2021 Oct; 249():104321. PubMed ID: 34242836
[TBL] [Abstract][Full Text] [Related]
4. UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats).
Maszczak-Seneczko D; Sosicka P; Kaczmarek B; Majkowski M; Luzarowski M; Olczak T; Olczak M
J Biol Chem; 2015 Jun; 290(25):15475-15486. PubMed ID: 25944901
[TBL] [Abstract][Full Text] [Related]
5. UDP-Gal/UDP-GlcNAc chimeric transporter complements mutation defect in mammalian cells deficient in UDP-Gal transporter.
Olczak M; Maszczak-Seneczko D; Sosicka P; Jakimowicz P; Olczak T
Biochem Biophys Res Commun; 2013 May; 434(3):473-8. PubMed ID: 23583405
[TBL] [Abstract][Full Text] [Related]
6. An insight into the orphan nucleotide sugar transporter SLC35A4.
Sosicka P; Maszczak-Seneczko D; Bazan B; Shauchuk Y; Kaczmarek B; Olczak M
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):825-838. PubMed ID: 28167211
[TBL] [Abstract][Full Text] [Related]
7. UDP-N-acetylglucosamine transporter and UDP-galactose transporter form heterologous complexes in the Golgi membrane.
Maszczak-Seneczko D; Sosicka P; Majkowski M; Olczak T; Olczak M
FEBS Lett; 2012 Nov; 586(23):4082-7. PubMed ID: 23089177
[TBL] [Abstract][Full Text] [Related]
8. N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme-multi-transporter assemblies in golgi membranes in vivo.
Khoder-Agha F; Sosicka P; Escriva Conde M; Hassinen A; Glumoff T; Olczak M; Kellokumpu S
Cell Mol Life Sci; 2019 May; 76(9):1821-1832. PubMed ID: 30737517
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of UDP-GlcNAc transporter partially corrects galactosylation defect caused by UDP-Gal transporter mutation.
Maszczak-Seneczko D; Olczak T; Jakimowicz P; Olczak M
FEBS Lett; 2011 Oct; 585(19):3090-4. PubMed ID: 21889501
[TBL] [Abstract][Full Text] [Related]
11. SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization.
Wiertelak W; Chabowska K; Szulc B; Zadorozhna Y; Olczak M; Maszczak-Seneczko D
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119462. PubMed ID: 36933771
[TBL] [Abstract][Full Text] [Related]
12. Short N-terminal region of UDP-galactose transporter (SLC35A2) is crucial for galactosylation of N-glycans.
Sosicka P; Jakimowicz P; Olczak T; Olczak M
Biochem Biophys Res Commun; 2014 Nov; 454(4):486-92. PubMed ID: 25451267
[TBL] [Abstract][Full Text] [Related]
13. Conserved Glu-47 and Lys-50 residues are critical for UDP-
Toscanini MA; Favarolo MB; Gonzalez Flecha FL; Ebert B; Rautengarten C; Bredeston LM
J Biol Chem; 2019 Jun; 294(26):10042-10054. PubMed ID: 31118275
[TBL] [Abstract][Full Text] [Related]
14. SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.
Ng BG; Sosicka P; Agadi S; Almannai M; Bacino CA; Barone R; Botto LD; Burton JE; Carlston C; Chung BH; Cohen JS; Coman D; Dipple KM; Dorrani N; Dobyns WB; Elias AF; Epstein L; Gahl WA; Garozzo D; Hammer TB; Haven J; Héron D; Herzog M; Hoganson GE; Hunter JM; Jain M; Juusola J; Lakhani S; Lee H; Lee J; Lewis K; Longo N; Lourenço CM; Mak CCY; McKnight D; Mendelsohn BA; Mignot C; Mirzaa G; Mitchell W; Muhle H; Nelson SF; Olczak M; Palmer CGS; Partikian A; Patterson MC; Pierson TM; Quinonez SC; Regan BM; Ross ME; Guillen Sacoto MJ; Scaglia F; Scheffer IE; Segal D; Singhal NS; Striano P; Sturiale L; Symonds JD; Tang S; Vilain E; Willis M; Wolfe LA; Yang H; Yano S; Powis Z; Suchy SF; Rosenfeld JA; Edmondson AC; Grunewald S; Freeze HH
Hum Mutat; 2019 Jul; 40(7):908-925. PubMed ID: 30817854
[TBL] [Abstract][Full Text] [Related]
15. UDP-N-acetylglucosamine transporter (SLC35A3) regulates biosynthesis of highly branched N-glycans and keratan sulfate.
Maszczak-Seneczko D; Sosicka P; Olczak T; Jakimowicz P; Majkowski M; Olczak M
J Biol Chem; 2013 Jul; 288(30):21850-60. PubMed ID: 23766508
[TBL] [Abstract][Full Text] [Related]
16. A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2.
Li D; Mukhopadhyay S
J Biol Chem; 2021 Sep; 297(3):101069. PubMed ID: 34384782
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation.
Cheng H; Wang S; Gao D; Yu K; Chen H; Huang Y; Li M; Zhang J; Guo K
Cell Oncol (Dordr); 2023 Apr; 46(2):283-297. PubMed ID: 36454514
[TBL] [Abstract][Full Text] [Related]
18. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy.
Kodera H; Nakamura K; Osaka H; Maegaki Y; Haginoya K; Mizumoto S; Kato M; Okamoto N; Iai M; Kondo Y; Nishiyama K; Tsurusaki Y; Nakashima M; Miyake N; Hayasaka K; Sugahara K; Yuasa I; Wada Y; Matsumoto N; Saitsu H
Hum Mutat; 2013 Dec; 34(12):1708-14. PubMed ID: 24115232
[TBL] [Abstract][Full Text] [Related]
19. Functional analyses of the UDP-galactose transporter SLC35A2 using the binding of bacterial Shiga toxins as a novel activity assay.
Li D; Mukhopadhyay S
Glycobiology; 2019 Jun; 29(6):490-503. PubMed ID: 30834435
[TBL] [Abstract][Full Text] [Related]
20. SLC35A2-CDG: Novel variant and review.
Quelhas D; Correia J; Jaeken J; Azevedo L; Lopes-Marques M; Bandeira A; Keldermans L; Matthijs G; Sturiale L; Martins E
Mol Genet Metab Rep; 2021 Mar; 26():100717. PubMed ID: 33552911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
